FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

28 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q4 2019.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.29M shares of 27.5M outstanding shares and own 33.85% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), Avoro Capital Advisors LLC (1.11M shares), Solas Capital Management, LLC (972K shares), 683 Capital Management, LLC (950K shares), Sonic Fund II, L.P. (835K shares), EVENTIDE ASSET MANAGEMENT, LLC (720K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (386K shares), OXFORD ASSET MANAGEMENT LLP (59.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (56.8K shares), and Hartford Financial Management Inc. (35K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.